Search Results - Lothar Bergmann

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
    Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients

    Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients by Wolfgang Andreas Nockher, Lothar Bergmann, Jürgen E. Scherberich

    Published 1994
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options

    Non-Clear Cell Renal Cell Carcinoma - Pathology and Treatment Options by Marit Ahrens, Sebastian Scheich, Arndt Hartmann, Lothar Bergmann

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia

    Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia by Lothar Bergmann, Klaus Fenchel, Bernhard Jahn, P.S. Mitrou, D. Hoelzer

    Published 1993
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia

    High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia by T. Karakas, Ulrich Maurer, Eckhart Weidmann, C.C. Miething, D. Hoelzer, Lothar Bergmann

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome

    High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome by Lothar Bergmann, Cornelius Miething, Ulrich Maurer, Jürgen Brieger, T. Karakas, Eckhart Weidmann, Dieter Hoelzer

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Mechanisms of Bcr-Abl-mediated NF-κB/Rel activation

    Mechanisms of Bcr-Abl-mediated NF-κB/Rel activation by Dieter Kirchner, Justus Duyster, Oliver G. Ottmann, Roland M. Schmid, Lothar Bergmann, Gerd Munzert

    Published 2003
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-κB/Rel–regulated inhibitors of apoptosis

    Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-κB/Rel–regulated inhibitors of apoptosis by Gerd Munzert, Dieter Kirchner, H Stobbe, Lothar Bergmann, Roland M. Schmid, Hartmut Döhner, H. Heimpel

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Simultaneous expression of different immunogenic antigens in acute myeloid leukemia

    Simultaneous expression of different immunogenic antigens in acute myeloid leukemia by Jochen Greiner, Mark Ringhoffer, Oliver Simikopinko, Anita Szmaragowska, Sandra Huebsch, Ulrich Maurer, Lothar Bergmann, Michael Schmitt

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease

    Whole-body 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin’s disease by Markus Bangerter, Florian Moog, Inga Buchmann, J. Kotzerke, Martin Grießhammer, Matthias Häfner, Klaus Elsner, Norbert Frickhofen, S. N. Reske, Lothar Bergmann

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia

    Receptor for hyaluronan acid–mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia by Jochen Greiner, Mark Ringhoffer, Masanori Taniguchi, Anita Schmitt, Dieter Kirchner, Gertraud Krähn, V. Heilmann, Jürgen E. Gschwend, Lothar Bergmann, Hartmut Döhner, Michael Schmitt

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

    The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic... by Iordanis Gravanis, Kyriaki Tzogani, Paula B. van Hennik, Pieter A. de Graeff, Petra M. Schmitt, Jan Mueller-Berghaus, Tomas Salmonson, Christian Gisselbrecht, Edward Laane, Lothar Bergmann, Francesco Pignatti

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study

    Rhenium 188–labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid le... by Donald Bunjes, Inga Buchmann, Christian Duncker, Ulrike Seitz, Jörg Kotzerke, Markus Wiesneth, Dagmar Dohr, Martin Štefanič, Andreas K. Buck, S. von Harsdorf, Gerhard Glatting, W. Grimminger, T. Karakas, Gerd Munzert, Hartmut Döhner, Lothar Bergmann, Sven N. Reske

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Interleukin-2- and Interferon Alfa-2a-Based Immunochemotherapy in Advanced Renal Cell Carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

    Interleukin-2- and Interferon Alfa-2a-Based Immunochemotherapy in Advanced Renal Cell Carcinoma: A Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimm... by Jens Atzpodien, Hartmut Kirchner, Udo Jonas, Lothar Bergmann, Harold C. Schott, H. Heynemann, Paolo Fornara, S.A. Loening, Jan Roigas, Stefan C. Müller, H. Bodenstein, S. Pomer, Bernd Metzner, U. Rebmann, R. Oberneder, M. Siebels, T Wandert, T. Puchberger, Martina Reitz

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

    Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2 by Peter Palmer, J. Vinke, Thierry Philip, Sylvie Négrier, Jens Atzpodien, Hartmut Kirchner, R. Oskam, C.R. Franks, Hans von der Maase, Nicholas Thatcher, C Jasmin, Sophie D. Fosså, Michel Symann, Lucien Israël, G Nagel, G. Stoter, C Rugarli, O Eremin, A Iacone, F. J. Cleton, Jozef Janssens, Willems, Lothar Bergmann, W. H. West, R. K. Oldham, Robert A. Dillman, Peter H. Wiernik, Charles A. Coltman, A. Raynor, James H. Doroshow, David Parkinson, E. Gallignoni, P J Guillou, Martin Gore, C.W. Keen, J. Timmons Roberts, Alexander Z. Harris, M. Fordham, P. Harper, M A Cornbleet, P Selby, Barry W. Hancock, N. Bleehan, S. J. Harland, Charles M. Rowland, Marek Ostrowski, Terry J. Hamblin, P S Veitch, M. Sokal, Paul G. Abrams, R.T.D. Oliver, H. Bodenstein, P. Czygan, PHM de Mulder, J. Wils

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Defining the critical hurdles in cancer immunotherapy

    Defining the critical hurdles in cancer immunotherapy by Bernard A. Fox, Dolores J. Schendel, Lisa H. Butterfield, Steinar Aamdal, James P. Allison, Paolo A. Ascierto, Michael B. Atkins, Jiřina Bartůňková, Lothar Bergmann, Neil L. Berinstein, Cristina C Bonorino, Ernest C. Borden, Jonathan L. Bramson, Cedrik M. Britten, Xuetao Cao, William E. Carson, Alfred E. Chang, Dainius Characiejus, Aniruddha Choudhury, George Coukos, Tanja D. de Gruijl, Robert O. Dillman, Harry Dolstra, Glenn Dranoff, Lindy G. Durrant, James H. Finke, Jérôme Galon, Jared Gollob, Cécile Gouttefangeas, Fabio Grizzi, Michele Guida, Leif Håkansson, Kristen Hege, Ronald B. Herberman, F. Stephen Hodi, Axel Hoos, Christoph Huber, Patrick Hwu, Kohzoh Imai, Elizabeth M. Jaffee, Sylvia Janetzki, Carl H. June, Paweł Kaliński, Howard L. Kaufman, Koji Kawakami, Yutaka Kawakami, Ulrich Keilholtz, Samir N. Khleif, Rolf Kiessling, Beatrix Kotlán, Guido Kroemer, Réjean Lapointe, Hyam I. Levitsky, Michael T. Lotze, Cristina Maccalli, Michele Maio, Jens‐Peter Marschner, Michael J. Mastrangelo, Giuseppe Masucci, Ignacio Melero, C.J.M. Melief, William J. Murphy, Brad H. Nelson, Andrea Nicolini, Michael I. Nishimura, Kunle Odunsi, Pamela S. Ohashi, Jill O’Donnell-Tormey, Lloyd J. Old, Christian H. Ottensmeier, Michael Papamichail, Giorgio Parmiani, Graham Pawelec, Enrico Proietti, Shukui Qin, Robert C. Rees, Antoni Ribas, Ruggero Ridolfi, Gerd Ritter, Licia Rivoltini, Pedro Romero, Mohamed L. Salem, Rik J. Scheper, Barbara Seliger, Padmanee Sharma, Hiroshi Shiku, Harpreet Singh‐Jasuja, Wenru Song, Per thor Straten, Hideaki Tahara, Zhigang Tian, Sjoerd H. van der Burg, Paul von Hoegen, Ena Wang, Marij J.P. Welters, H. Winter, Tara Withington, Jedd D. Wolchok, Weihua Xiao, Laurence Zitvogel

    Published 2011
    Get full text Get full text
    Editorial
    Save to List
    Saved in:

Search Tools: